---
$id: https://graph.org.ai/products/commodity/51142559
$type: Product
source: UNSPSC
code: "51142559"
title: "Pergolide mesilate or mesylate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pergolide mesilate or mesylate

**UNSPSC Code**: 51142559
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C19H26N2S.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 55B9HQY616, chemically known as ergoline, 8-((methylthio)methyl)-6-propyl-, monomethanesulfonate, (8beta)- but more generally known as pergolide mesilate, which bears US NIH Compound Identifier 47812. European Medicines Agency schedules Pergolide mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03709MIG. Most nations, for tariff and trade purposes, schedule pergolide mesylate under HS 29396900. As of Q4 2014, PERGOLIDE MESYLATE remains US FDA's Preferred Term for this commodity. Pergolide mesylate bears US NLM identifiers UMLS ID C0701027 and NCI Concept Code C47665. SMILES: CCCN1C[C@@H](C[C@H]2[C@H]1CC3C[NH]C4C3C2CCC4)CSC.CS(=O)(=O)O.

